NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
about
Metabolic syndrome is associated with increased risk of Barrett esophagus: A meta-analysis.Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewBarrett's esophagus: best practices for treatment and post-treatment surveillance.Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.Oxidative stress from reflux esophagitis to esophageal cancer: the alleviation with antioxidants.Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population.Redirecting the focus of cancer immunotherapy to premalignant conditions.Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma.Risk prediction in Barrett's esophagus - aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment.Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women.Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.Aspirin acts in esophageal cancer: a brief review.Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
P2860
Q30248613-D810A7C4-98C2-41D2-8F63-978582226890Q36245569-28B36EAB-AB3E-4A38-8FA4-73D5123222EAQ37542809-910D078E-4E14-4ADF-967D-85AA45FDFE01Q37747384-079601D9-A995-48E1-BC55-F5359A2AD508Q38435302-6E608237-AF28-4E4D-B60F-4F85DA447BF9Q38816252-DFB416B2-D4E5-429B-A76C-E6D1F9274FA2Q38965723-F527B77C-62BA-4558-950D-EA329961A310Q39107022-0A673D61-DF04-4F78-B556-172A9689C969Q39425042-5DE30283-E78C-422F-8F25-D0B221D1F5A1Q39550675-AE3450E0-EFED-4EEA-A205-EC1B39500AA6Q40522077-E70A261E-1110-4B20-B538-C595C6894983Q49227522-5DAE7F58-933A-4603-B765-E45335F9C9F8Q55312563-F3360249-1D4F-413A-88D6-800328154863Q55375453-E42F297C-0EF1-46F4-9569-912916F8E8A8Q58800614-91240EED-CFCF-4003-B8F8-2592343C67C2
P2860
NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
NSAIDs, statins, low-dose aspi ...... tion-based case-control study.
@en
type
label
NSAIDs, statins, low-dose aspi ...... tion-based case-control study.
@en
prefLabel
NSAIDs, statins, low-dose aspi ...... tion-based case-control study.
@en
P2860
P50
P1433
P1476
NSAIDs, statins, low-dose aspi ...... ation-based case-control study
@en
P2093
Gwen M C Masclee
Preciosa M Coloma
P2860
P304
P356
10.1136/BMJOPEN-2014-006640
P577
2015-01-29T00:00:00Z